ID   MIB1_HUMAN              Reviewed;        1006 AA.
AC   Q86YT6; B0YJ38; Q2TB37; Q68D01; Q6YI51; Q8NBY0; Q8TCB5; Q8TCL7;
AC   Q9P2M3;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   10-MAY-2017, entry version 143.
DE   RecName: Full=E3 ubiquitin-protein ligase MIB1;
DE            EC=2.3.2.27;
DE   AltName: Full=DAPK-interacting protein 1;
DE            Short=DIP-1;
DE   AltName: Full=Mind bomb homolog 1;
DE   AltName: Full=RING-type E3 ubiquitin transferase MIB1 {ECO:0000305};
DE   AltName: Full=Zinc finger ZZ type with ankyrin repeat domain protein 2;
GN   Name=MIB1; Synonyms=DIP1, KIAA1323, ZZANK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=12530964; DOI=10.1016/S1534-5807(02)00409-4;
RA   Itoh M., Kim C.-H., Palardy G., Oda T., Jiang Y.-J., Maust D.,
RA   Yeo S.-Y., Lorick K., Wright G.J., Ariza-McNaughton L., Weissman A.M.,
RA   Lewis J., Chandrasekharappa S.C., Chitnis A.B.;
RT   "Mind bomb is a ubiquitin ligase that is essential for efficient
RT   activation of Notch signaling by Delta.";
RL   Dev. Cell 4:67-82(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Yoo K.-W., Chitnis A., Kim C.-H.;
RL   Submitted (SEP-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 195-1006.
RC   TISSUE=Amygdala, and Endometrial tumor;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 611-1006, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI.
RT   The complete sequences of 150 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 627-1006.
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   POSSIBLE SUBCELLULAR LOCATION.
RX   PubMed=15048887; DOI=10.1002/ana.20001;
RA   Henshall D.C., Schindler C.K., So N.K., Lan J.-Q., Meller R.,
RA   Simon R.P.;
RT   "Death-associated protein kinase expression in human temporal lobe
RT   epilepsy.";
RL   Ann. Neurol. 55:485-494(2004).
RN   [9]
RP   UBIQUITINATION OF TBK1.
RX   PubMed=21903422; DOI=10.1016/j.immuni.2011.06.014;
RA   Li S., Wang L., Berman M., Kong Y.Y., Dorf M.E.;
RT   "Mapping a dynamic innate immunity protein interaction network
RT   regulating type I interferon production.";
RL   Immunity 35:426-440(2011).
RN   [10]
RP   FUNCTION IN UBIQUITINATION OF CEP131 AND PCM1, FUNCTION IN
RP   CILIOGENESIS, UBIQUITINATION, INTERACTION WITH CEP131 AND PCM1, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=24121310; DOI=10.1038/emboj.2013.223;
RA   Villumsen B.H., Danielsen J.R., Povlsen L., Sylvestersen K.B.,
RA   Merdes A., Beli P., Yang Y.G., Choudhary C., Nielsen M.L., Mailand N.,
RA   Bekker-Jensen S.;
RT   "A new cellular stress response that triggers centriolar satellite
RT   reorganization and ciliogenesis.";
RL   EMBO J. 32:3029-3040(2013).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-408, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   VARIANT HIS-174.
RX   PubMed=23033978; DOI=10.1056/NEJMoa1206524;
RA   de Ligt J., Willemsen M.H., van Bon B.W., Kleefstra T., Yntema H.G.,
RA   Kroes T., Vulto-van Silfhout A.T., Koolen D.A., de Vries P.,
RA   Gilissen C., del Rosario M., Hoischen A., Scheffer H., de Vries B.B.,
RA   Brunner H.G., Veltman J.A., Vissers L.E.;
RT   "Diagnostic exome sequencing in persons with severe intellectual
RT   disability.";
RL   N. Engl. J. Med. 367:1921-1929(2012).
RN   [13]
RP   VARIANT LVNC7 PHE-943.
RX   PubMed=23314057; DOI=10.1038/nm.3046;
RA   Luxan G., Casanova J.C., Martinez-Poveda B., Prados B., D'Amato G.,
RA   MacGrogan D., Gonzalez-Rajal A., Dobarro D., Torroja C., Martinez F.,
RA   Izquierdo-Garcia J.L., Fernandez-Friera L., Sabater-Molina M.,
RA   Kong Y.Y., Pizarro G., Ibanez B., Medrano C., Garcia-Pavia P.,
RA   Gimeno J.R., Monserrat L., Jimenez-Borreguero L.J., de la Pompa J.L.;
RT   "Mutations in the NOTCH pathway regulator MIB1 cause left ventricular
RT   noncompaction cardiomyopathy.";
RL   Nat. Med. 19:193-201(2013).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that mediates ubiquitination
CC       of Delta receptors, which act as ligands of Notch proteins.
CC       Positively regulates the Delta-mediated Notch signaling by
CC       ubiquitinating the intracellular domain of Delta, leading to
CC       endocytosis of Delta receptors. Probably mediates ubiquitination
CC       and subsequent proteasomal degradation of DAPK1, thereby
CC       antagonizing anti-apoptotic effects of DAPK1 to promote TNF-
CC       induced apoptosis (By similarity). Involved in ubiquitination of
CC       centriolar satellite CEP131, CEP290 and PCM1 proteins and hence
CC       inhibits primary cilium formation in proliferating cells. Mediates
CC       'Lys-63'-linked polyubiquitination of TBK1, which probably
CC       participates in kinase activation. {ECO:0000250,
CC       ECO:0000269|PubMed:24121310}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with CEP131 and PCM1.
CC       {ECO:0000269|PubMed:24121310}.
CC   -!- INTERACTION:
CC       Q9QYP6:Azi2 (xeno); NbExp=2; IntAct=EBI-2129148, EBI-6115874;
CC       Q9UHD2:TBK1; NbExp=2; IntAct=EBI-2129148, EBI-356402;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:24121310}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center,
CC       centrosome, centriolar satellite {ECO:0000269|PubMed:24121310}.
CC       Cell membrane {ECO:0000250}. Note=Localizes to the plasma membrane
CC       (By similarity). According to PubMed:15048887, it is
CC       mitochondrial, however such localization remains unclear.
CC       Displaced from centriolar satellites in response to cellular
CC       stress, such as ultraviolet light (UV) radiation or heat shock.
CC       {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Widely expressed at low level. Expressed at
CC       higher level in spinal cord, ovary, whole brain, and all specific
CC       brain regions examined. {ECO:0000269|PubMed:10718198}.
CC   -!- PTM: Ubiquitinated; possibly via autoubiquitination (By
CC       similarity). Ubiquitinated; this modification is inhibited in
CC       response to cellular stress, such as ultraviolet light (UV)
CC       radiation or heat shock. {ECO:0000250,
CC       ECO:0000269|PubMed:21903422, ECO:0000269|PubMed:24121310}.
CC   -!- DISEASE: Left ventricular non-compaction 7 (LVNC7) [MIM:615092]: A
CC       disease due to an arrest of myocardial morphogenesis. It is
CC       characterized by a hypertrophic left ventricle with deep
CC       trabeculations and with poor systolic function, with or without
CC       associated left ventricular dilation. In some cases, it is
CC       associated with other congenital heart anomalies.
CC       {ECO:0000269|PubMed:23314057}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: In epilepsy brain tissue, levels of expression are
CC       increased in the cytoplasm and microsomal fractions (endoplasmic
CC       reticulum).
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH22403.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAN18023.1; Type=Frameshift; Positions=3; Evidence={ECO:0000305};
CC       Sequence=BAC11439.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY149908; AAN75493.1; -; mRNA.
DR   EMBL; AY147849; AAN18023.1; ALT_FRAME; mRNA.
DR   EMBL; EF444995; ACA06016.1; -; Genomic_DNA.
DR   EMBL; BC022403; AAH22403.1; ALT_INIT; mRNA.
DR   EMBL; BC110581; AAI10582.1; -; mRNA.
DR   EMBL; BC110582; AAI10583.1; -; mRNA.
DR   EMBL; CR749635; CAH18429.1; -; mRNA.
DR   EMBL; AL713705; CAD28502.1; -; mRNA.
DR   EMBL; AB037744; BAA92561.1; -; mRNA.
DR   EMBL; AK075157; BAC11439.1; ALT_INIT; mRNA.
DR   CCDS; CCDS11871.1; -.
DR   RefSeq; NP_065825.1; NM_020774.3.
DR   UniGene; Hs.140903; -.
DR   PDB; 4TSE; X-ray; 2.06 A; A/B=239-409.
DR   PDB; 4XI6; X-ray; 2.04 A; A=8-402.
DR   PDB; 4XI7; X-ray; 2.05 A; A=8-402.
DR   PDB; 4XIB; X-ray; 2.15 A; A=8-402.
DR   PDBsum; 4TSE; -.
DR   PDBsum; 4XI6; -.
DR   PDBsum; 4XI7; -.
DR   PDBsum; 4XIB; -.
DR   ProteinModelPortal; Q86YT6; -.
DR   SMR; Q86YT6; -.
DR   BioGrid; 121593; 73.
DR   IntAct; Q86YT6; 40.
DR   MINT; MINT-2841371; -.
DR   STRING; 9606.ENSP00000261537; -.
DR   iPTMnet; Q86YT6; -.
DR   PhosphoSitePlus; Q86YT6; -.
DR   DMDM; 68565512; -.
DR   EPD; Q86YT6; -.
DR   MaxQB; Q86YT6; -.
DR   PaxDb; Q86YT6; -.
DR   PeptideAtlas; Q86YT6; -.
DR   PRIDE; Q86YT6; -.
DR   Ensembl; ENST00000261537; ENSP00000261537; ENSG00000101752.
DR   GeneID; 57534; -.
DR   KEGG; hsa:57534; -.
DR   UCSC; uc002ktq.5; human.
DR   CTD; 57534; -.
DR   DisGeNET; 57534; -.
DR   GeneCards; MIB1; -.
DR   HGNC; HGNC:21086; MIB1.
DR   HPA; CAB037044; -.
DR   HPA; HPA019100; -.
DR   MalaCards; MIB1; -.
DR   MIM; 608677; gene.
DR   MIM; 615092; phenotype.
DR   neXtProt; NX_Q86YT6; -.
DR   OpenTargets; ENSG00000101752; -.
DR   Orphanet; 54260; Left ventricular noncompaction.
DR   PharmGKB; PA134862722; -.
DR   eggNOG; KOG0504; Eukaryota.
DR   eggNOG; KOG4582; Eukaryota.
DR   eggNOG; COG0666; LUCA.
DR   GeneTree; ENSGT00790000122981; -.
DR   HOVERGEN; HBG068386; -.
DR   InParanoid; Q86YT6; -.
DR   KO; K10645; -.
DR   OMA; CYNERKT; -.
DR   OrthoDB; EOG091G00Z0; -.
DR   PhylomeDB; Q86YT6; -.
DR   TreeFam; TF324147; -.
DR   Reactome; R-HSA-2122948; Activated NOTCH1 Transmits Signal to the Nucleus.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2691232; Constitutive Signaling by NOTCH1 HD Domain Mutants.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-2979096; NOTCH2 Activation and Transmission of Signal to the Nucleus.
DR   SignaLink; Q86YT6; -.
DR   SIGNOR; Q86YT6; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; MIB1; human.
DR   GeneWiki; MIB1_(gene); -.
DR   GenomeRNAi; 57534; -.
DR   PRO; PR:Q86YT6; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000101752; -.
DR   CleanEx; HS_MIB1; -.
DR   Genevisible; Q86YT6; HS.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0001568; P:blood vessel development; IEA:Ensembl.
DR   GO; GO:0006897; P:endocytosis; IBA:GO_Central.
DR   GO; GO:0001947; P:heart looping; IEA:Ensembl.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0001841; P:neural tube formation; IEA:Ensembl.
DR   GO; GO:0007219; P:Notch signaling pathway; IBA:GO_Central.
DR   GO; GO:0045807; P:positive regulation of endocytosis; IEA:Ensembl.
DR   GO; GO:0001756; P:somitogenesis; IEA:Ensembl.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 1.25.40.20; -; 3.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR010606; Mib_Herc2.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR000433; Znf_ZZ.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF06701; MIB_HERC2; 2.
DR   Pfam; PF00569; ZZ; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 9.
DR   SMART; SM00184; RING; 3.
DR   SMART; SM00291; ZnF_ZZ; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 6.
DR   PROSITE; PS51416; MIB_HERC2; 2.
DR   PROSITE; PS50089; ZF_RING_2; 3.
DR   PROSITE; PS01357; ZF_ZZ_1; 1.
DR   PROSITE; PS50135; ZF_ZZ_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ANK repeat; Cell membrane; Coiled coil;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Disease mutation;
KW   Membrane; Metal-binding; Notch signaling pathway; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Transferase;
KW   Ubl conjugation; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1   1006       E3 ubiquitin-protein ligase MIB1.
FT                                /FTId=PRO_0000055943.
FT   DOMAIN        6     74       MIB/HERC2 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00749}.
FT   DOMAIN      143    221       MIB/HERC2 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00749}.
FT   REPEAT      430    460       ANK 1.
FT   REPEAT      463    492       ANK 2.
FT   REPEAT      496    525       ANK 3.
FT   REPEAT      529    558       ANK 4.
FT   REPEAT      562    591       ANK 5.
FT   REPEAT      595    627       ANK 6.
FT   REPEAT      631    661       ANK 7.
FT   REPEAT      665    694       ANK 8.
FT   REPEAT      698    729       ANK 9.
FT   ZN_FING      79    126       ZZ-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00228}.
FT   ZN_FING     819    854       RING-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   ZN_FING     866    901       RING-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   ZN_FING     963    996       RING-type 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   COILED      935    962       {ECO:0000255}.
FT   MOD_RES     408    408       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VARIANT     174    174       R -> H (found in a patient with severe
FT                                mental retardation, psychomotor delay, no
FT                                speech, sleep disturbances, feeding
FT                                problems, abnormal breething, deep-set
FT                                eyes and short philtrum;
FT                                dbSNP:rs755375969).
FT                                {ECO:0000269|PubMed:23033978}.
FT                                /FTId=VAR_069385.
FT   VARIANT     943    943       V -> F (in LVNC7; dbSNP:rs200035428).
FT                                {ECO:0000269|PubMed:23314057}.
FT                                /FTId=VAR_069620.
FT   CONFLICT    327    327       E -> K (in Ref. 2; AAN18023).
FT                                {ECO:0000305}.
FT   CONFLICT    398    398       S -> F (in Ref. 2; AAN18023).
FT                                {ECO:0000305}.
FT   STRAND       17     20       {ECO:0000244|PDB:4XI6}.
FT   TURN         27     30       {ECO:0000244|PDB:4XI6}.
FT   STRAND       37     52       {ECO:0000244|PDB:4XI6}.
FT   STRAND       57     66       {ECO:0000244|PDB:4XI6}.
FT   STRAND       68     72       {ECO:0000244|PDB:4XI6}.
FT   HELIX        74     76       {ECO:0000244|PDB:4XI6}.
FT   TURN         86     88       {ECO:0000244|PDB:4XI6}.
FT   STRAND       91    105       {ECO:0000244|PDB:4XI6}.
FT   HELIX       110    114       {ECO:0000244|PDB:4XI6}.
FT   STRAND      124    127       {ECO:0000244|PDB:4XI6}.
FT   HELIX       140    142       {ECO:0000244|PDB:4XI6}.
FT   STRAND      145    152       {ECO:0000244|PDB:4XI6}.
FT   STRAND      156    159       {ECO:0000244|PDB:4XI6}.
FT   TURN        166    169       {ECO:0000244|PDB:4XI6}.
FT   STRAND      176    182       {ECO:0000244|PDB:4XI6}.
FT   STRAND      192    197       {ECO:0000244|PDB:4XI6}.
FT   STRAND      202    208       {ECO:0000244|PDB:4XI6}.
FT   HELIX       209    211       {ECO:0000244|PDB:4XI6}.
FT   STRAND      215    219       {ECO:0000244|PDB:4XI6}.
FT   STRAND      221    227       {ECO:0000244|PDB:4XI6}.
FT   HELIX       228    230       {ECO:0000244|PDB:4XI6}.
FT   STRAND      251    253       {ECO:0000244|PDB:4TSE}.
FT   HELIX       258    264       {ECO:0000244|PDB:4XI6}.
FT   TURN        265    269       {ECO:0000244|PDB:4XI6}.
FT   HELIX       273    276       {ECO:0000244|PDB:4XI6}.
FT   HELIX       277    280       {ECO:0000244|PDB:4XI6}.
FT   STRAND      283    288       {ECO:0000244|PDB:4XI6}.
FT   TURN        290    292       {ECO:0000244|PDB:4XIB}.
FT   STRAND      294    297       {ECO:0000244|PDB:4XI6}.
FT   STRAND      303    306       {ECO:0000244|PDB:4XI6}.
FT   HELIX       308    310       {ECO:0000244|PDB:4XI6}.
FT   STRAND      338    341       {ECO:0000244|PDB:4XI6}.
FT   HELIX       345    354       {ECO:0000244|PDB:4XI6}.
FT   HELIX       360    365       {ECO:0000244|PDB:4XI6}.
FT   STRAND      369    375       {ECO:0000244|PDB:4XI6}.
FT   STRAND      381    385       {ECO:0000244|PDB:4XI6}.
FT   STRAND      388    392       {ECO:0000244|PDB:4XI6}.
FT   HELIX       394    396       {ECO:0000244|PDB:4XI6}.
FT   STRAND      397    399       {ECO:0000244|PDB:4XI6}.
FT   STRAND      402    405       {ECO:0000244|PDB:4TSE}.
SQ   SEQUENCE   1006 AA;  110136 MW;  5D7D0D91AF98FF18 CRC64;
     MSNSRNNRVM VEGVGARVVR GPDWKWGKQD GGEGHVGTVR SFESPEEVVV VWDNGTAANY
     RCSGAYDLRI LDSAPTGIKH DGTMCDTCRQ QPIIGIRWKC AECTNYDLCT VCYHGDKHHL
     RHRFYRITTP GSERVLLESR RKSKKITARG IFAGARVVRG VDWQWEDQDG GNGRRGKVTE
     IQDWSASSPH SAAYVLWDNG AKNLYRVGFE GMSDLKCVQD AKGGSFYRDH CPVLGEQNGN
     RNPGGLQIGD LVNIDLDLEI VQSLQHGHGG WTDGMFETLT TTGTVCGIDE DHDIVVQYPS
     GNRWTFNPAV LTKANIVRSG DAAQGAEGGT SQFQVGDLVQ VCYDLERIKL LQRGHGEWAE
     AMLPTLGKVG RVQQIYSDSD LKVEVCGTSW TYNPAAVSKV ASAGSAISNA SGERLSQLLK
     KLFETQESGD LNEELVKAAA NGDVAKVEDL LKRPDVDVNG QCAGHTAMQA ASQNGHVDIL
     KLLLKQNVDV EAEDKDGDRA VHHAAFGDEG AVIEVLHRGS ADLNARNKRR QTPLHIAVNK
     GHLQVVKTLL DFGCHPSLQD SEGDTPLHDA ISKKRDDILA VLLEAGADVT ITNNNGFNAL
     HHAALRGNPS AMRVLLSKLP RPWIVDEKKD DGYTALHLAA LNNHVEVAEL LVHQGNANLD
     IQNVNQQTAL HLAVERQHTQ IVRLLVRAGA KLDIQDKDGD TPLHEALRHH TLSQLRQLQD
     MQDVGKVDAA WEPSKNTLIM GLGTQGAEKK SAASIACFLA ANGADLSIRN KKGQSPLDLC
     PDPNLCKALA KCHKEKVSGQ VGSRSPSMIS NDSETLEECM VCSDMKRDTL FGPCGHIATC
     SLCSPRVKKC LICKEQVQSR TKIEECVVCS DKKAAVLFQP CGHMCACENC ANLMKKCVQC
     RAVVERRVPF IMCCGGKSSE DATDDISSGN IPVLQKDKDN TNVNADVQKL QQQLQDIKEQ
     TMCPVCLDRL KNMIFLCGHG TCQLCGDRMS ECPICRKAIE RRILLY
//
